Do analysts prefer APHA or SLS?

Solaris Resources has a consensus target price of C$19.50, suggesting a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts clearly believe Solaris Resources is more favorable than Aphria. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Is APHA or SLS more profitable?

Solaris Resources' return on equity of 60.97% beat Aphria's return on equity. Company Net Margins Return on Equity Return on Assets Aphria N/A N/A N/A Solaris Resources N/A 60.97% -51.67%

Do analysts prefer SLS or BHC?

Solaris Resources presently has a consensus target price of C$19.50, indicating a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher probable upside, research analysts clearly believe Solaris Resources is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer SLS or AUP?

Solaris Resources presently has a consensus target price of C$19.50, indicating a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher probable upside, equities analysts clearly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is SLS or AUP more profitable?

Solaris Resources' return on equity of 60.97% beat Aurinia Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Solaris Resources N/A 60.97% -51.67% Aurinia Pharmaceuticals N/A N/A N/A

Do analysts rate SLS or CARA?

Solaris Resources presently has a consensus target price of C$19.50, indicating a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher possible upside, equities research analysts clearly believe Solaris Resources is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, SLS or CARA?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solaris Resources N/A N/A -C$46.49M -C$0.19 N/A Cara Operations N/A N/A N/A N/A N/A

Is SLS or CARA more profitable?

Solaris Resources' return on equity of 60.97% beat Cara Operations' return on equity. Company Net Margins Return on Equity Return on Assets Solaris Resources N/A 60.97% -51.67% Cara Operations N/A N/A N/A

Solaris Resources (SLS) Competitors

C$10.79 -0.01 (-0.09%)

As of 07/24/2026 04:00 PM Eastern

Compare

SLS vs. APHA, PBH, BHC, AUP, and CARA

Should you buy Solaris Resources stock or one of its competitors? MarketBeat compares Solaris Resources with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Solaris Resources include Aphria (APHA), Premium Brands (PBH), Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Solaris Resources compare to Aphria?

Aphria (TSE:APHA) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

In the previous week, Aphria's average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score.

Company	Overall Sentiment
Aphria	Neutral
Solaris Resources	Neutral

Solaris Resources' return on equity of 60.97% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aphria	N/A	N/A	N/A
Solaris Resources	N/A	60.97%	-51.67%

16.5% of Solaris Resources shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Solaris Resources has lower revenue, but higher earnings than Aphria. Solaris Resources is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

Solaris Resources has a consensus target price of C$19.50, suggesting a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts clearly believe Solaris Resources is more favorable than Aphria.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Solaris Resources beats Aphria on 8 of the 11 factors compared between the two stocks.

How does Solaris Resources compare to Premium Brands?

Solaris Resources (TSE:SLS) and Premium Brands (TSE:PBH) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

Premium Brands has higher revenue and earnings than Solaris Resources. Solaris Resources is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Premium Brands	C$7.88B	0.59	C$99.56M	C$0.90	98.68

Solaris Resources has a beta of 1.777576, meaning that its stock price is 78% more volatile than the broader market. Comparatively, Premium Brands has a beta of 0.901611, meaning that its stock price is 10% less volatile than the broader market.

In the previous week, Premium Brands had 4 more articles in the media than Solaris Resources. MarketBeat recorded 4 mentions for Premium Brands and 0 mentions for Solaris Resources. Premium Brands' average media sentiment score of 0.15 beat Solaris Resources' score of 0.00 indicating that Premium Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
Solaris Resources	Neutral
Premium Brands	Neutral

Premium Brands has a net margin of 0.52% compared to Solaris Resources' net margin of 0.00%. Solaris Resources' return on equity of 60.97% beat Premium Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Premium Brands	0.52%	2.21%	3.61%

Solaris Resources presently has a consensus price target of C$19.50, indicating a potential upside of 80.72%. Premium Brands has a consensus price target of C$118.62, indicating a potential upside of 33.56%. Given Solaris Resources' stronger consensus rating and higher probable upside, equities research analysts plainly believe Solaris Resources is more favorable than Premium Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92

16.5% of Solaris Resources shares are owned by institutional investors. Comparatively, 32.5% of Premium Brands shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by company insiders. Comparatively, 2.0% of Premium Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Premium Brands beats Solaris Resources on 10 of the 15 factors compared between the two stocks.

How does Solaris Resources compare to Bausch Health Companies?

Solaris Resources (TSE:SLS) and Bausch Health Companies (TSE:BHC) are both pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

In the previous week, Bausch Health Companies had 6 more articles in the media than Solaris Resources. MarketBeat recorded 6 mentions for Bausch Health Companies and 0 mentions for Solaris Resources. Bausch Health Companies' average media sentiment score of 2.00 beat Solaris Resources' score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company	Overall Sentiment
Solaris Resources	Neutral
Bausch Health Companies	Very Positive

Solaris Resources has higher earnings, but lower revenue than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Bausch Health Companies	C$10.53B	0.22	-C$125.65M	-C$3.24	N/A

Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Solaris Resources' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Bausch Health Companies	-13.54%	120.43%	4.16%

Solaris Resources has a beta of 1.777576, meaning that its share price is 78% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.973491, meaning that its share price is 3% less volatile than the broader market.

16.5% of Solaris Resources shares are held by institutional investors. Comparatively, 10.7% of Bausch Health Companies shares are held by institutional investors. 40.6% of Solaris Resources shares are held by insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Solaris Resources presently has a consensus target price of C$19.50, indicating a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher probable upside, research analysts clearly believe Solaris Resources is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Solaris Resources beats Bausch Health Companies on 9 of the 15 factors compared between the two stocks.

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Solaris Resources (TSE:SLS) and Aurinia Pharmaceuticals (TSE:AUP) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Solaris Resources' return on equity of 60.97% beat Aurinia Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Aurinia Pharmaceuticals	N/A	N/A	N/A

Solaris Resources has higher earnings, but lower revenue than Aurinia Pharmaceuticals. Solaris Resources is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A

16.5% of Solaris Resources shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Solaris Resources presently has a consensus target price of C$19.50, indicating a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher probable upside, equities analysts clearly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Solaris Resources' average media sentiment score of 0.00 equaled Aurinia Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Solaris Resources	Neutral
Aurinia Pharmaceuticals	Neutral

Summary

Solaris Resources beats Aurinia Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

How does Solaris Resources compare to Cara Operations?

Solaris Resources (TSE:SLS) and Cara Operations (TSE:CARA) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Cara Operations	N/A	N/A	N/A	N/A	N/A

Solaris Resources' return on equity of 60.97% beat Cara Operations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Cara Operations	N/A	N/A	N/A

Solaris Resources presently has a consensus target price of C$19.50, indicating a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher possible upside, equities research analysts clearly believe Solaris Resources is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

16.5% of Solaris Resources shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Solaris Resources' average media sentiment score of 0.00 equaled Cara Operations'average media sentiment score.

Company	Overall Sentiment
Solaris Resources	Neutral
Cara Operations	Neutral

Summary

Solaris Resources beats Cara Operations on 6 of the 7 factors compared between the two stocks.

Get Solaris Resources News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SLS vs. The Competition

Export

Metric	Solaris Resources	Other Precious Metals & Mining Industry	Materials Sector	TSE Exchange
Market Cap	C$1.80B	C$579.79M	C$4.56B	C$12.48B
Dividend Yield	N/A	6.10%	5.02%	6.19%
P/E Ratio	-56.79	12.44	20.95	36.95
Price / Sales	N/A	3,595.10	5,752.36	9.44
Price / Cash	64.53	13.04	26.33	82.29
Price / Book	-35.77	56.14	8.57	4.39
Net Income	-C$46.49M	-C$4.87M	C$157.08M	C$299.09M
7 Day Performance	8.55%	3.60%	1.24%	0.61%
1 Month Performance	-6.34%	1.30%	-1.23%	1.06%
1 Year Performance	57.98%	43.65%	35.93%	30.89%

Solaris Resources Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SLS Solaris Resources	1.419 of 5 stars	C$10.79 -0.1%	C$19.50 +80.7%	+56.6%	C$1.80B	N/A	N/A	10
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
PBH Premium Brands	3.6785 of 5 stars	C$88.70 -2.9%	C$118.62 +33.7%	0.0%	C$4.61B	C$7.88B	98.56	540
BHC Bausch Health Companies	0.895 of 5 stars	C$6.28 -2.5%	N/A	-32.4%	C$2.35B	C$10.53B	N/A	19,900	News Coverage Analyst Upgrade Analyst Revision
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:SLS) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solaris Resources (SLS) Competitors

SLS vs. APHA, PBH, BHC, AUP, and CARA

How does Solaris Resources compare to Aphria?

Summary

How does Solaris Resources compare to Premium Brands?

Summary

How does Solaris Resources compare to Bausch Health Companies?

Summary

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Summary

How does Solaris Resources compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLS vs. The Competition

Solaris Resources Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Solaris Resources (SLS) Competitors

SLS vs. APHA, PBH, BHC, AUP, and CARA

How does Solaris Resources compare to Aphria?

Does the media prefer APHA or SLS?

Is APHA or SLS more profitable?

Do institutionals and insiders have more ownership in APHA or SLS?

Which has better earnings and valuation, APHA or SLS?

Do analysts prefer APHA or SLS?

Summary

How does Solaris Resources compare to Premium Brands?

Which has preferable earnings and valuation, SLS or PBH?

Which has more risk and volatility, SLS or PBH?

Does the media favor SLS or PBH?

Is SLS or PBH more profitable?

Do analysts rate SLS or PBH?

Do insiders and institutionals believe in SLS or PBH?

Summary

How does Solaris Resources compare to Bausch Health Companies?

Does the media prefer SLS or BHC?

Which has preferable valuation and earnings, SLS or BHC?

Is SLS or BHC more profitable?

Which has more risk & volatility, SLS or BHC?

Do institutionals & insiders have more ownership in SLS or BHC?

Do analysts prefer SLS or BHC?

Summary

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Is SLS or AUP more profitable?

Which has better valuation & earnings, SLS or AUP?

Do insiders and institutionals have more ownership in SLS or AUP?

Do analysts prefer SLS or AUP?

Does the media refer more to SLS or AUP?

Summary

How does Solaris Resources compare to Cara Operations?

Which has preferable earnings & valuation, SLS or CARA?

Is SLS or CARA more profitable?

Do analysts rate SLS or CARA?

Do institutionals and insiders have more ownership in SLS or CARA?

Does the media favor SLS or CARA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLS vs. The Competition

Solaris Resources Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools